Byakangelicin

CAS: 482-25-7

Ref. 3D-FB65595

Produktinformation

• Name: Byakangelicin
• Synonyme: 9-{[(2R)-2,3-Dihydroxy-3-methylbutyl]oxy}-4-methoxy-7H-furo[3,2-g]chromen-7-one, (+)-Byakangelicin, 5-Methoxy-8-(2,3-dihydroxy-3-methylbutoxy)psoralene, 7H-FURO(3,2-g)(1)BENZOPYRAN-7-ONE, 9-(2,3-DIHYDROXY-3-METHYLBUTOXY)-4-METHOXY-,, 7H-Furo[3,2-g][1]benzopyran-7-one, 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-, (R)-, 7H-Furo[3,2-g][1]benzopyran-7-one, 9-[(2R)-2,3-dihydroxy-3-methylbutoxy]-4-methoxy-, 9-[(2R)-2,3-Dihydroxy-3-methylbutoxy]-4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one, Biacangelicin, Bjacangelicin, Bjakangelicin, Byankagelicine

Beschreibung

Byakangelicin is a natural compound that has anti-cancer properties. It inhibits the growth of cancer cells by binding to the DNA and RNA. Byakangelicin binds to the nitrogen atoms in the molecule, preventing it from binding to other molecules and inhibiting protein synthesis. It also inhibits platelet aggregation, making it useful for treating diabetic neuropathy. Byakangelicin has been shown to have pharmacokinetic properties including a high oral bioavailability, a low toxicity, and a long half-life. These properties make it an attractive candidate for drug development and clinical use in humans.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 334.32 g/mol
• Formel: C₁₇H₁₈O₇
• Reinheit: Min. 95%
• Farbe/Form: Powder
• InChl: InChI=1S/C17H18O7/c1-17(2,20)11(18)8-23-16-14-10(6-7-22-14)13(21-3)9-4-5-12(19)24-15(9)16/h4-7,11,18,20H,8H2,1-3H3/t11-/m1/s1
• InChI Key: InChIKey=PKRPFNXROFUNDE-LLVKDONJSA-N
• SMILES: COc1c2ccoc2c(OC[C@@H](O)C(C)(C)O)c2oc(=O)ccc12